
FDA Approves Merck’s New Live Ebola Vaccine Which It Says Can Shed and Cause Immunosuppression
Merck has received the FDA’s fast-tracked approval of a live, genetically modified Ebola vaccine which, according to its vaccine insert, can cause a novel new form